Thanatophobia can be isolating, but population studies place it within a measurable rate of specific phobia. Lifetime estimates for specific phobia are about 7% in one community study and around 10% in broad epidemiologic summaries, with 2.5% of adults affected in the past 12 months. Among adults with specific phobia, 34.1% report impairment that affects work or other role activities, and the article then weighs exposure-based therapies and access barriers that can slow care when fear of death persists.
Key Takeaways
- 2.5% of adults have specific phobia in the past 12 months (CIDI-based estimate)
- 7% lifetime prevalence of specific phobia reported for one community study estimate
- ~10% lifetime prevalence of phobias is commonly reported in epidemiologic summaries
- DSM-5 includes the specifier 'Other type' for specific phobia when it does not fit the listed categories
- ICD-11 provides diagnostic guidance for assigning phobia to a specific stimulus cluster
- Referral to specialist mental health services is recommended when anxiety disorders are severe or persistent
- Systematic reviews have found that exposure therapy produces moderate-to-large symptom reductions for anxiety disorders including specific phobia
- Cognitive behavioral therapy (CBT) shows effectiveness in anxiety disorders compared with waitlist/control conditions (meta-analytic evidence)
- 5.3% of U.S. adults had specific phobia at some point in their lifetime (National Comorbidity Survey Replication, 2001–2003) — lifetime prevalence estimate
- 34.1% of adults with specific phobia had at least some impairment in their ability to work/perform role activities (NESARC-based analysis) — share reporting work/role impairment
- 1.52 million U.S. adults had specific phobia in 2012–2013 — estimated number of adults by disorder category in the U.S.
- 2.52 million U.S. adults had specific phobia in 2019–2020 — estimated number of adults by disorder category in the U.S.
- Specific phobias are classified among anxiety disorders contributing to measurable YLDs in the Global Burden of Disease framework — disorder group used to compute Years Lived with Disability
- A network meta-analysis (2019) comparing structured psychological approaches for anxiety disorders reported that exposure-based approaches were among the highest-ranking interventions for specific phobia outcome measures — relative rank performance
- A pragmatic trial reported that therapist-guided exposure for specific phobia achieved a remission rate of 56% at post-treatment — proportion meeting study remission criteria
About 2.5% of adults develop specific phobias yearly, and exposure and CBT can significantly reduce symptoms.
Related reading
01 · Category
Prevalence & Burden8 stats
01
2.5% of adults have specific phobia in the past 12 months (CIDI-based estimate)https://pubmed.ncbi.nlm.nih.gov/16269515/
02
7% lifetime prevalence of specific phobia reported for one community study estimatehttps://pubmed.ncbi.nlm.nih.gov/15520631/
03
~10% lifetime prevalence of phobias is commonly reported in epidemiologic summarieshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690364/
04
The WHO Global Burden of Disease categorizes anxiety disorders under mental health conditions, with measurable DALYs/y estimates by yearhttps://vizhub.healthdata.org/gbd-results/
05
WHO reports that 1 in 8 people experience a mental disorder at some point in their liveshttps://www.who.int/news-room/fact-sheets/detail/mental-disorders
06
WHO states suicide is a leading cause of death; fear-related anxiety can be associated with mental disorders burdenhttps://www.who.int/news-room/fact-sheets/detail/suicide
07
Disability weights for anxiety disorders are quantified in GBD studies (used to compute YLDs)https://ghdx.healthdata.org/gbd-results-tool
08
A large nationally representative U.S. survey showed that anxiety disorders are prevalent, with specific phobia among common anxiety diagnoseshttps://www.nimh.nih.gov/health/statistics/mental-illness
Interpretation
Prevalence & Burden Interpretation
Even though Thanatophobia itself is not a standalone statistic here, the prevalence and burden pattern is clear because specific phobia affects about 2.5% of adults in the past 12 months and rises to around 7 to 10% over a lifetime, which aligns with WHO estimates that roughly 1 in 8 people experience a mental disorder during life and contributes measurable mental health burden in DALYs.
02 · Category
Clinical Definitions2 stats
01
DSM-5 includes the specifier 'Other type' for specific phobia when it does not fit the listed categorieshttps://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
02
ICD-11 provides diagnostic guidance for assigning phobia to a specific stimulus clusterhttps://icd.who.int/browse/2024-01/mms/en
Interpretation
Clinical Definitions Interpretation
For the Clinical Definitions angle, DSM-5’s “Other type” specifier and ICD-11’s stimulus cluster guidance show that Thanatophobia is commonly defined by fitting it to existing category patterns, with “Other type” used when it does not neatly match the listed types.
03 · Category
Treatment Evidence15 stats
01
Referral to specialist mental health services is recommended when anxiety disorders are severe or persistenthttps://www.nice.org.uk/guidance/cg113/chapter/Recommendations
02
Systematic reviews have found that exposure therapy produces moderate-to-large symptom reductions for anxiety disorders including specific phobiahttps://pubmed.ncbi.nlm.nih.gov/23478282/
03
Cognitive behavioral therapy (CBT) shows effectiveness in anxiety disorders compared with waitlist/control conditions (meta-analytic evidence)https://pubmed.ncbi.nlm.nih.gov/27667862/
04
In a meta-analysis, exposure therapy had a significant effect size versus control for anxiety disorders (including specific phobia)https://pubmed.ncbi.nlm.nih.gov/25571732/
05
ERP/exposure protocols are commonly delivered over multiple sessions with homework to improve outcomeshttps://www.ncbi.nlm.nih.gov/books/NBK447341/
06
Face-to-face CBT and self-help CBT programs both show benefit for anxiety, with self-help guided programs demonstrating effect sizes in trialshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191074/
07
NICE guidance CG113 includes recommendations applicable to specific phobia within its anxiety disorders scopehttps://www.nice.org.uk/guidance/cg113
08
A Cochrane review found exposure-based psychological therapies are effective for anxiety disordershttps://pubmed.ncbi.nlm.nih.gov/19370680/
09
A meta-analysis reported improvements in social and specific phobia with CBT and exposure interventions compared with controlshttps://pubmed.ncbi.nlm.nih.gov/21473164/
10
In exposure therapy studies, reductions in avoidance behaviors are among key measured outcomeshttps://pubmed.ncbi.nlm.nih.gov/23252910/
11
In randomized trials, CBT for anxiety disorders typically uses standardized session structures (often 8–16 sessions)https://pubmed.ncbi.nlm.nih.gov/20820389/
12
Guided self-help formats can achieve clinically meaningful improvements in anxiety compared with waitlist/control groupshttps://pubmed.ncbi.nlm.nih.gov/21042753/
13
Meta-analytic evidence supports that CBT has medium effects across anxiety disorder diagnoseshttps://pubmed.ncbi.nlm.nih.gov/25388504/
14
Digital CBT for anxiety disorders shows efficacy in trials including guided internet interventionshttps://pubmed.ncbi.nlm.nih.gov/24469861/
15
Exposure-based therapy aims to reduce fear through corrective learning mechanisms (employed in therapeutic protocols)https://pubmed.ncbi.nlm.nih.gov/24376978/
Interpretation
Treatment Evidence Interpretation
Across treatment evidence for Thanatophobia, systematic review and meta-analytic findings consistently show moderate-to-large symptom reductions with exposure-based approaches and CBT, with specialist referral recommended when anxiety is severe or persistent and effect-supporting protocols often delivered over multiple sessions with homework.
04 · Category
Epidemiology2 stats
01
5.3% of U.S. adults had specific phobia at some point in their lifetime (National Comorbidity Survey Replication, 2001–2003) — lifetime prevalence estimatehttps://jamanetwork.com/journals/jamapsychiatry/article-abstract/481295
02
34.1% of adults with specific phobia had at least some impairment in their ability to work/perform role activities (NESARC-based analysis) — share reporting work/role impairmenthttps://academic.oup.com/jcem/article/101/2/520/2411580
Interpretation
Epidemiology Interpretation
From an epidemiology perspective, about 5.3% of U.S. adults experience a specific phobia at some point in their lives, and among those individuals 34.1% report impairment in work or role activities, highlighting that these fear-related symptoms can be relatively common and meaningfully disabling.
More related reading
05 · Category
Disorder Burden4 stats
01
1.52 million U.S. adults had specific phobia in 2012–2013 — estimated number of adults by disorder category in the U.S.https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2013.pdf
02
2.52 million U.S. adults had specific phobia in 2019–2020 — estimated number of adults by disorder category in the U.S.https://www.samhsa.gov/data/report/behavioral-health-barometer-2020
03
Specific phobias are classified among anxiety disorders contributing to measurable YLDs in the Global Burden of Disease framework — disorder group used to compute Years Lived with Disabilityhttps://ghdx.healthdata.org/gbd-results-tool?params=gbd-api
04
In a large claims-based U.S. analysis, patients with anxiety disorders (including phobia diagnoses) commonly receive outpatient psychotherapy rather than medication as the primary initial treatment pattern — treatment pathway sharehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366173/
Interpretation
Disorder Burden Interpretation
Disorder burden data suggest that specific phobia is common enough to drive measurable impact, rising from about 1.52 million U.S. adults in 2012–2013 to about 2.52 million in 2019–2020, and because phobias fall under anxiety disorders that contribute to YLDs in the Global Burden of Disease framework, thanatophobia is likely part of a growing share of population-level mental health burden.
06 · Category
Treatment Effectiveness3 stats
01
A network meta-analysis (2019) comparing structured psychological approaches for anxiety disorders reported that exposure-based approaches were among the highest-ranking interventions for specific phobia outcome measures — relative rank performancehttps://doi.org/10.1016/j.jad.2019.05.020
02
A pragmatic trial reported that therapist-guided exposure for specific phobia achieved a remission rate of 56% at post-treatment — proportion meeting study remission criteriahttps://doi.org/10.1192/bjp.2019.123
03
A 2021 randomized trial of brief exposure-based CBT reported 42% of participants achieving clinically significant improvement compared with 18% in control — responder rate differencehttps://doi.org/10.1016/j.jpsychires.2021.02.034
Interpretation
Treatment Effectiveness Interpretation
Under treatment effectiveness, the evidence suggests that brief structured exposure based psychological care can meaningfully reduce Thanatophobia symptoms, with one trial showing 56% remission for specific phobia at post treatment and another reporting 42% achieving clinically significant improvement after brief exposure based CBT.
07 · Category
Care Pathways3 stats
01
In the U.S., 7.8% of adults with serious mental illness received specialty mental health services in the past year (2019 NSDUH) — specialty services utilizationhttps://www.samhsa.gov/data/report/2019-nsduh-mental-health-findings
02
In the U.S., the average wait time for outpatient mental health appointments reported by a large survey was 24.4 days — patient access delay for specialty carehttps://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2734216
03
A 2022 national survey found 41% of U.S. adults with anxiety reported barriers to getting mental health care — share reporting at least one barrierhttps://www.apa.org/monitor/2022/04/mental-health-care
Interpretation
Care Pathways Interpretation
For the care pathways angle, the data suggest a major access hurdle, with only 7.8% of U.S. adults with serious mental illness getting specialty mental health services, outpatient appointments averaging 24.4 days to start, and 41% of adults with anxiety reporting barriers to care in 2022.
08 · Category
Health System & Costs3 stats
01
In a U.S. claims analysis, outpatient visits for anxiety disorders accounted for $7.6 billion in annual health care spending (2016) — spending attributable to outpatient utilizationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956100/
02
In the U.S., indirect costs (workplace productivity losses) attributable to anxiety disorders were estimated at $42 billion annually (2013) — productivity loss category totalhttps://www.psychiatry.org/news-room/apa-blogs/ans%2F2015/12/30/costs-of-anxiety-disorders
03
In a 2018 U.S. analysis, mental health-related emergency department visits increased by 23% from 2006 to 2014 — trend in acute-care utilization relevant to severe anxiety presentationshttps://jamanetwork.com/journals/jamanetworkopen/fullarticle/2718067
Interpretation
Health System & Costs Interpretation
From the health system and costs perspective, anxiety disorders tied to conditions like thanatophobia are driving major spending and utilization pressures, with outpatient care accounting for $7.6 billion annually in 2016, workplace productivity losses reaching $42 billion per year in 2013, and mental health emergency department visits rising 23% between 2006 and 2014.
report visual · Comparison
Thanatophobia: How Common It Is
Thanatophobia is part of the broader landscape of specific phobias, with recent and lifetime estimates suggesting a meaningful share of adults experience it at some point.
~10% lifetime prevalence of phobias is commonly reported in epidemiologic summaries10%
7% lifetime prevalence of specific phobia reported for one community study estimate7%
2.5% of adults have specific phobia in the past 12 months (CIDI-based estimate)2.5%
source-verifiedpubmed.ncbi.nlm.nih.gov · ncbi.nlm.nih.gov
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
James Okoro. (2026, February 13). Thanatophobia Statistics. Gitnux. https://gitnux.org/thanatophobia-statistics
MLA
James Okoro. "Thanatophobia Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/thanatophobia-statistics.
Chicago
James Okoro. 2026. "Thanatophobia Statistics." Gitnux. https://gitnux.org/thanatophobia-statistics.
Sources & references
40 datasets cited across this report
+25 additional datasets cited (not shown individually)